Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
!!T3 IRESSA ASTRAZENECA CANADA INC Actual shortage 250MG Updated Report 2025-10-09 257363
!!T3 BENZACLIN BAUSCH HEALTH, CANADA INC. Actual shortage 1% 5% New Report 2025-10-09 257530
DUKORAL VALNEVA SWEDEN AB Actual shortage 1MG 31250000000CELLS 31250000000CELLS 31250000000CELLS 31250000000CELLS Updated Report 2025-10-08 257524
ACCOLATE TAB 20 MG ASTRAZENECA CANADA INC Actual shortage 20MG Updated Report 2025-10-08 257212
ONDEXXYA ASTRAZENECA CANADA INC Actual shortage 200MG Updated Report 2025-10-08 257138
Regan Dickerson ROSAIRE BELISLE ET FILS INC. Actual shortage Optio qui dolor rec Updated Report 2025-10-03 257505
Francesca Oneil ERFA CANADA 2012 INC Avoided shortage Et veniam ab irure Updated Report 2025-10-01 257483
Len Patton ULTRA CHEM LABS CANADA CORP. Anticipated shortage Rerum consequatur Q Updated Report 2025-10-01 257478
Rudyard Mclaughlin NANOSONICS LIMITED Avoided shortage Cupiditate amet qui Updated Report 2025-10-01 257475
test 6646158 CANADA INC. Actual shortage test New Report 2025-09-29 257455

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
!!T3 POTASSIUM CHLORIDE 40 MEQ IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE ICU MEDICAL CANADA INC Discontinued 33.3MG 2.98MG 3.00MG Updated Report 2025-10-09 56260
AVAXIM SANOFI PASTEUR LIMITED To be discontinued 160UNIT New Report 2025-10-08 257527
DORZOLAMIDE AND TIMOLOL EYE DROPS BP HIKMA CANADA LIMITED Discontinued 5MG 20MG Updated Report 2025-10-08 241852
ARIMIDEX ASTRAZENECA CANADA INC Discontinued 1MG Updated Report 2025-10-07 257343
TEZSPIRE ASTRAZENECA CANADA INC To be discontinued 110MG Updated Report 2025-10-07 257378
Get it on Google Play Download on the App Store